NASDAQ : DSGN
Design Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.68 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 668.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 58.78M | 59.13M | 44.35M | 57.06M | 48.61M | 24.78M |
| Gross Profit | -58.78M | -59.13M | -44.35M | -57.06M | -48.61M | -24.78M |
| Selling, General & Admin | 20.18M | 19.94M | 18.03M | 21.13M | 18.98M | 11.05M |
| Operating Expenses | 20.18M | 19.94M | 18.03M | 21.13M | 18.98M | 11.05M |
| Operating Income | -78.96M | -79.07M | -62.38M | -78.19M | -67.59M | -35.83M |
| Interest & Investment Income | 8.57M | 9.68M | 12.79M | 11.33M | ||
| Other Non Operating Income (Expenses) | 2.89M | 221.00K | ||||
| EBT Excluding Unusual Items | -70.39M | -69.39M | -49.59M | -66.86M | -64.70M | -35.61M |
| Gain (Loss) on Sale of Investments | 1.40M | 77.00K | ||||
| Other Unusual Items | -400.00K | -400.00K | ||||
| Pretax Income | -70.80M | -69.79M | -49.59M | -66.86M | -63.31M | -35.53M |
| Net Income | -70.80M | -69.79M | -49.59M | -66.86M | -63.31M | -35.53M |
| Net Income to Common | -70.80M | -69.79M | -49.59M | -66.86M | -63.31M | -35.53M |
| Shares Outstanding (Basic) | 59.91M | 57.33M | 56.59M | 55.98M | 55.71M | 45.94M |
| Shares Outstanding (Diluted) | 59.91M | 57.33M | 56.59M | 55.98M | 55.71M | 45.94M |
| EPS (Basic) | -1.18 | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 |
| EPS (Diluted) | -1.18 | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 |
| Free Cash Flow | -55.14M | -54.55M | -43.45M | -58.82M | -52.23M | -30.91M |
| Free Cash Flow Per Share | -0.92 | -0.95 | -0.77 | -1.05 | -0.94 | -0.67 |
| EBITDA | -78.34M | -78.44M | -61.79M | -77.65M | -67.19M | -35.70M |
| D&A For EBITDA | 619.00K | 622.00K | 596.00K | 537.00K | 406.00K | 129.00K |
| EBIT | -78.96M | -79.07M | -62.38M | -78.19M | -67.59M | -35.83M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.91M | 16.86M | 22.56M | 21.20M | 26.50M | 298.57M |
| Short-Term Investments | 194.49M | 202.99M | 222.91M | 260.60M | 303.89M | 85.50M |
| Cash & Short-Term Investments | 207.40M | 219.84M | 245.48M | 281.80M | 330.39M | 384.06M |
| Other Receivables | 1.79M | 1.68M | 1.26M | 1.43M | 1.11M | 110.00K |
| Receivables | 1.79M | 1.68M | 1.26M | 1.43M | 1.11M | 110.00K |
| Prepaid Expenses | 2.83M | 2.26M | 1.30M | 1.35M | 3.62M | 1.26M |
| Total Current Assets | 212.01M | 223.78M | 248.04M | 284.58M | 335.12M | 385.44M |
| Property, Plant & Equipment | 3.12M | 2.42M | 3.63M | 4.63M | 5.56M | 5.12M |
| Other Long-Term Assets | 427.00K | 430.00K | 459.00K | |||
| Total Assets | 215.13M | 226.20M | 252.09M | 289.64M | 341.14M | 390.56M |
| Accounts Payable | 3.14M | 2.31M | 2.19M | 1.94M | 3.02M | 1.62M |
| Accrued Expenses | 7.47M | 9.85M | 5.48M | 6.97M | 7.11M | 3.17M |
| Current Portion of Leases | 631.00K | 890.00K | 800.00K | 716.00K | 640.00K | 489.00K |
| Total Current Liabilities | 11.24M | 13.05M | 8.46M | 9.62M | 10.78M | 5.28M |
| Long-Term Leases | 2.03M | 645.00K | 1.53M | 2.33M | 3.05M | 3.14M |
| Total Liabilities | 13.27M | 13.70M | 10.00M | 11.96M | 13.83M | 8.43M |
| Common Stock | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Additional Paid-In Capital | 537.43M | 509.10M | 468.83M | 455.25M | 441.42M | 429.82M |
| Retained Earnings | -334.81M | -297.01M | -227.21M | -177.63M | -110.76M | -47.46M |
| Comprehensive Income & Other | -771.00K | 403.00K | 475.00K | 62.00K | -3.36M | -244.00K |
| Total Common Equity | 201.86M | 212.50M | 242.10M | 277.69M | 327.31M | 382.13M |
| Shareholders' Equity | 201.86M | 212.50M | 242.10M | 277.69M | 327.31M | 382.13M |
| Total Liabilities & Equity | 215.13M | 226.20M | 252.09M | 289.64M | 341.14M | 390.56M |
| Total Debt | 2.66M | 1.53M | 2.33M | 3.05M | 3.69M | 3.63M |
| Net Cash (Debt) | 204.73M | 218.31M | 243.14M | 278.75M | 326.70M | 380.43M |
| Net Cash Per Share | 3.42 | 3.81 | 4.30 | 4.98 | 5.86 | 8.28 |
| Filing Date Shares Outstanding | 62.58M | 61.67M | 56.76M | 56.49M | 55.90M | 55.46M |
| Total Common Shares Outstanding | 62.58M | 60.40M | 56.75M | 56.47M | 55.90M | 55.44M |
| Working Capital | 200.77M | 210.73M | 239.58M | 274.96M | 324.34M | 380.15M |
| Book Value Per Share | 3.23 | 3.52 | 4.27 | 4.92 | 5.86 | 6.89 |
| Tangible Book Value | 201.86M | 212.50M | 242.10M | 277.69M | 327.31M | 382.13M |
| Tangible Book Value Per Share | 3.23 | 3.52 | 4.27 | 4.92 | 5.86 | 6.89 |
| Machinery | 3.09M | 3.07M | 2.91M | 2.60M | 2.32M | 1.54M |
| Construction In Progress | 11.00K | |||||
| Leasehold Improvements | 172.00K | 172.00K | 151.00K | 151.00K | 151.00K | 95.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -70.80M | -69.79M | -49.59M | -66.86M | -63.31M | -35.53M |
| Depreciation & Amortization | 619.00K | 622.00K | 596.00K | 537.00K | 406.00K | 129.00K |
| Loss (Gain) From Sale of Investments | -1.44M | -3.25M | -6.20M | -6.08M | -1.40M | -77.00K |
| Stock-Based Compensation | 14.82M | 14.55M | 13.07M | 13.09M | 10.93M | 4.69M |
| Other Operating Activities | 128.00K | 406.00K | 6.00K | 33.00K | 64.00K | 19.00K |
| Change in Accounts Payable | 2.69M | 4.49M | -1.22M | -1.25M | 5.38M | 2.41M |
| Change in Other Net Operating Assets | -1.10M | -1.38M | 226.00K | 1.97M | -3.39M | -1.02M |
| Operating Cash Flow | -55.08M | -54.36M | -43.10M | -58.56M | -51.32M | -29.38M |
| Capital Expenditures | -55.00K | -193.00K | -340.00K | -256.00K | -918.00K | -1.54M |
| Sale of Property, Plant & Equipment | 39.00K | |||||
| Investment in Securities | 2.45M | 23.11M | 44.30M | 52.79M | -220.11M | -52.11M |
| Investing Cash Flow | 2.39M | 22.91M | 43.95M | 52.54M | -220.99M | -53.64M |
| Issuance of Common Stock | 45.89M | 25.74M | 513.00K | 724.00K | 662.00K | 254.50M |
| Other Financing Activities | -427.00K | |||||
| Financing Cash Flow | 45.89M | 25.74M | 513.00K | 724.00K | 235.00K | 379.21M |
| Net Cash Flow | -6.80M | -5.71M | 1.36M | -5.30M | -272.07M | 296.19M |
| Free Cash Flow | -55.14M | -54.55M | -43.45M | -58.82M | -52.23M | -30.91M |
| Free Cash Flow Per Share | -0.92 | -0.95 | -0.77 | -1.05 | -0.94 | -0.67 |
| Levered Free Cash Flow | -32.36M | -31.31M | -26.68M | -34.78M | -29.85M | -17.88M |
| Unlevered Free Cash Flow | -32.36M | -31.31M | -26.68M | -34.78M | -29.85M | -17.88M |
| Change in Working Capital | 1.59M | 3.11M | -993.00K | 728.00K | 1.99M | 1.40M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 657.11M | 534.32M | 349.35M | 148.40M | 572.92M | 1.18B |
| Enterprise Value | 452.37M | 330.09M | 97.80M | -139.32M | 232.53M | 792.55M |
| Last Close Price | 10.68 | 9.38 | 6.17 | 2.65 | 10.26 | 21.41 |
| PB Ratio | 3.31 | 2.51 | 1.44 | 0.53 | 1.75 | 3.10 |
| P/TBV Ratio | 3.31 | 2.51 | 1.44 | 0.53 | 1.75 | 3.10 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.01 | -1.03 | -1.00 | -1.00 | -1.00 | -1.00 |
| Net Debt / EBITDA Ratio | 2.61 | 2.78 | 3.94 | 3.59 | 4.86 | 10.66 |
| Net Debt / FCF Ratio | 3.71 | 4.00 | 5.60 | 4.74 | 6.25 | 12.31 |
| Quick Ratio | 18.61 | 16.97 | 29.16 | 29.44 | 30.76 | 72.72 |
| Current Ratio | 18.86 | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 |
| Return on Equity (ROE) | -34.13% | -30.70% | -19.08% | -22.10% | -17.85% | -17.08% |
| Return on Assets (ROA) | -22.53% | -20.66% | -14.39% | -15.50% | -11.55% | -10.49% |
| Return on Capital Employed (ROCE) | -38.70% | -37.10% | -25.60% | -27.90% | -20.50% | -9.30% |
| Earnings Yield | -11.25% | -13.06% | -14.19% | -45.05% | -11.05% | -3.00% |
| FCF Yield | -8.25% | -10.21% | -12.44% | -39.63% | -9.12% | -2.61% |
| Buyback Yield / Dilution | -5.61% | -1.31% | -1.08% | -0.50% | -21.27% | -190.80% |